Works matching DE "EMTRICITABINE-tenofovir"

Results: 358
    1
    2
    3
    4

    Hydroxyzine Use and Mortality in Patients Hospitalized for COVID-19: A Multicenter Observational Study.

    Published in:
    Journal of Clinical Medicine, 2021, v. 10, n. 24, p. 5891, doi. 10.3390/jcm10245891
    By:
    • Sánchez-Rico, Marina;
    • Limosin, Frédéric;
    • Vernet, Raphaël;
    • Beeker, Nathanaël;
    • Neuraz, Antoine;
    • Blanco, Carlos;
    • Olfson, Mark;
    • Lemogne, Cédric;
    • Meneton, Pierre;
    • Daniel, Christel;
    • Paris, Nicolas;
    • Gramfort, Alexandre;
    • Lemaitre, Guillaume;
    • De La Muela, Pedro;
    • Salamanca, Elisa;
    • Bernaux, Mélodie;
    • Bellamine, Ali;
    • Burgun, Anita;
    • Hoertel, Nicolas
    Publication type:
    Article
    5
    6
    7
    8

    Acceptability and Use of the Dapivirine Vaginal Ring and Daily Oral Pre-exposure Prophylaxis (PrEP) During Breastfeeding in South Africa, Malawi, Zimbabwe, and Uganda.

    Published in:
    AIDS & Behavior, 2023, v. 27, n. 12, p. 4114, doi. 10.1007/s10461-023-04125-w
    By:
    • Stoner, Marie C. D.;
    • Hawley, Imogen;
    • Mathebula, Florence;
    • Horne, Elizea;
    • Etima, Juliane;
    • Kemigisha, Doreen;
    • Mutero, Prisca;
    • Dandadzi, Adlight;
    • Seyama, Linly;
    • Fabiano, Zayithwa;
    • Scheckter, Rachel;
    • Noguchi, Lisa;
    • Owor, Maxensia;
    • Balkus, Jennifer E.;
    • Montgomery, Elizabeth T.
    Publication type:
    Article
    9

    "I'd feel like someone was watchin' me... watching for a good reason": perceptions of data privacy, access, and sharing in the context of real-time PrEP adherence monitoring among HIV-negative MSM with substance use.

    Published in:
    AIDS & Behavior, 2022, v. 26, n. 9, p. 2981, doi. 10.1007/s10461-022-03614-8
    By:
    • Goodman, Georgia R.;
    • Kikut, Anna;
    • Bustamante, Maria J.;
    • Mendez, Lizette;
    • Mohamed, Yassir;
    • Shachar, Carmel;
    • Cohen, I. Glenn;
    • Gerke, Sara;
    • Boyer, Edward W.;
    • Rosen, Rochelle K.;
    • Mayer, Kenneth H.;
    • O'Cleirigh, Conall;
    • Chai, Peter R.
    Publication type:
    Article
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19

    Injectable Antiretroviral Drugs: Back to the Future.

    Published in:
    Viruses (1999-4915), 2021, v. 13, n. 2, p. 228, doi. 10.3390/v13020228
    By:
    • Berruti, Marco;
    • Riccardi, Niccolò;
    • Canetti, Diana;
    • Lo Caputo, Sergio;
    • Taramasso, Lucia;
    • Di Biagio, Antonio;
    • Van Grevenynghe, Julien
    Publication type:
    Article
    20
    21
    22
    23
    24

    To what extent do people living with HIV, people on pre-exposure prophylaxis, doctors and pharmacists endorse 90-day dispensing of antiretroviral therapy in France?

    Published in:
    PLoS ONE, 2022, v. 17, n. 4, p. 1, doi. 10.1371/journal.pone.0265166
    By:
    • Jacomet, Christine;
    • Goncalves, Émilie;
    • Lambert, Céline;
    • Chedorge, Didier;
    • Puglièse-Wehrlen, Sylvia;
    • Billaud, Éric;
    • Zucman, David;
    • Simon, Anne;
    • Arvieux, Cédric;
    • Trout, Hervé;
    • Laurandin, Bruno;
    • Maarek, René;
    • Raymond, Isabelle;
    • Puglièse, Pascal;
    • Langlois, Julie;
    • Certain, Agnès
    Publication type:
    Article
    25
    26
    27
    28
    29
    30

    Association of HIV Preexposure Prophylaxis Use With HIV Incidence Among Men Who Have Sex With Men in China: A Nonrandomized Controlled Trial.

    Published in:
    JAMA Network Open, 2022, v. 5, n. 2, p. e2148782, doi. 10.1001/jamanetworkopen.2021.48782
    By:
    • Wang, Hongyi;
    • Wang, Zixin;
    • Huang, Xiaojie;
    • Chen, Yaokai;
    • Wang, Hui;
    • Cui, Sitong;
    • Zhang, Jing;
    • Chu, Zhenxing;
    • Hu, Qinghai;
    • Ding, Haibo;
    • Qian, Hanzhu;
    • Zou, Huachun;
    • Tang, Weiming;
    • Gao, Yangyang;
    • Jin, Xia;
    • Liu, Zhaozhen;
    • Zhang, Lukun;
    • Zhao, Jin;
    • He, Xiaoqing;
    • Jiang, Yongjun
    Publication type:
    Article
    31
    32
    33

    Effectiveness, safety, and patient‐reported outcomes of emtricitabine/tenofovir alafenamide‐based regimens for the treatment of HIV‐1 infection: Final 24‐month results from the prospective German TAFNES cohort study.

    Published in:
    HIV Medicine, 2025, v. 26, n. 2, p. 239, doi. 10.1111/hiv.13728
    By:
    • Stephan, Christoph;
    • Spinner, Christoph D.;
    • Rieke, Ansgar;
    • Christensen, Stefan;
    • Mauss, Stefan;
    • Schreiber, Sandra;
    • Albuquerque, Boris;
    • Heinzkill, Marion;
    • Ramroth, Heribert;
    • Stellbrink, Hans‐Jürgen
    Publication type:
    Article
    34
    35

    Twelve‐month effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide in people with HIV: Real‐world insights from BICSTaR cohorts.

    Published in:
    HIV Medicine, 2024, v. 25, n. 4, p. 440, doi. 10.1111/hiv.13593
    By:
    • Esser, Stefan;
    • Brunetta, Jason;
    • Inciarte, Alexy;
    • Levy, Itzchak;
    • D'Arminio Monforte, Antonella;
    • Lambert, John S.;
    • van Welzen, Berend;
    • Teruya, Katsuji;
    • Boffito, Marta;
    • Liu, Chun‐Eng;
    • Altuntas Aydın, Ozlem;
    • Thorpe, David;
    • Heinzkill, Marion;
    • Marongiu, Andrea;
    • Cassidy, Tali;
    • Haubrich, Richard;
    • D'Amato, Lisa;
    • Robineau, Olivier
    Publication type:
    Article
    36
    37
    38

    BHIVA guidelines on antiretroviral treatment for adults living with HIV‐1 2022.

    Published in:
    HIV Medicine, 2022, v. 23, p. 3, doi. 10.1111/hiv.13446
    By:
    • Waters, Laura;
    • Winston, Alan;
    • Reeves, Iain;
    • Boffito, Marta;
    • Churchill, Duncan;
    • Cromarty, Ben;
    • Dunn, David;
    • Fink, Douglas;
    • Fidler, Sarah;
    • Foster, Caroline;
    • Fox, Julie;
    • Gupta, Ravi;
    • Hilton, Andy;
    • Khoo, Saye;
    • Leen, Clifford;
    • Mackie, Nicola;
    • Naous, Nadia;
    • Ogbonmwan, Daisy;
    • Orkin, Chloe;
    • Panton, Linda
    Publication type:
    Article
    39

    Major revision version 11.0 of the European AIDS Clinical Society Guidelines 2021.

    Published in:
    HIV Medicine, 2022, v. 23, n. 8, p. 849, doi. 10.1111/hiv.13268
    By:
    • Ryom, Lene;
    • De Miguel, Rosa;
    • Cotter, Aoife Grace;
    • Podlekareva, Daria;
    • Beguelin, Charles;
    • Waalewijn, Hylke;
    • Arribas, Josè R;
    • Mallon, Patrick W. G.;
    • Marzolini, Catia;
    • Kirk, Ole;
    • Bamford, Alasdair;
    • Rauch, Andri;
    • Molina, Jean Michel;
    • Kowalska, Justyna Dominika;
    • Guaraldi, Giovanni;
    • Winston, Alan;
    • Boesecke, Christoph;
    • Cinque, Paola;
    • Welch, Steven;
    • Collins, Simon
    Publication type:
    Article
    40
    41
    42

    Where are we with pre‐exposure prophylaxis use in Central and Eastern Europe? Data from the Euroguidelines in Central and Eastern Europe (ECEE) Network Group.

    Published in:
    HIV Medicine, 2021, v. 22, n. 1, p. 67, doi. 10.1111/hiv.12960
    By:
    • Balayan, T;
    • Begovac, J;
    • Skrzat‐Klapaczyńska, A;
    • Aho, I;
    • Alexiev, I;
    • Bukovinova, P;
    • Salemovic, D;
    • Gokengin, D;
    • Harxhi, A;
    • Holban, T;
    • Jevtovic, D;
    • Kase, K;
    • Lakatos, B;
    • Latysheva, I;
    • Matulionyte, R;
    • Oprea, C;
    • Papadopoulos, A;
    • Rukhadze, N;
    • Sedlacek, D;
    • Tomazic, J
    Publication type:
    Article
    43
    44
    45
    46
    47
    48

    First‐line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison.

    Published in:
    HIV Medicine, 2018, v. 19, n. 7, p. 475, doi. 10.1111/hiv.12628
    By:
    • Taramasso, L.;
    • Di Biagio, A.;
    • Maggiolo, F.;
    • Tavelli, A.;
    • Lo Caputo, S.;
    • Bonora, S.;
    • Zaccarelli, M.;
    • Caramello, P.;
    • Costantini, A.;
    • Viscoli, C.;
    • d'Arminio Monforte, A.;
    • Cozzi‐Lepri, A.;
    • the Italian Cohort Naive Antiretrovirals (ICONA) Foundation Study Group
    Publication type:
    Article
    49
    50